お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
969068

視神経脊髄炎 (デビック症候群):世界の治験動向 (2020年下半期)

Neuromyelitis Optica (Devic's Syndrome) Disease - Global Clinical Trials Review, H2 2020

出版日: | 発行: GlobalData | ページ情報: 英文 97 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.68円
視神経脊髄炎 (デビック症候群):世界の治験動向 (2020年下半期)
出版日: 2020年10月29日
発行: GlobalData
ページ情報: 英文 97 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、視神経脊髄炎 (デビック症候群) に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国およびE7諸国における治験の状況、地域別・フェーズ別 (相別)・段階別の進行状況、有望なスポンサー (治験依頼者)、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んでお届けします。

目次

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5ヶ国における治験件数
    • 中南米の主要5ヶ国における治験件数

G7諸国での治験件数:中枢神経系疾患の治験件数に対する視神経脊髄炎 (デビック症候群) の比率

G7諸国での治験件数:相別 (フェーズ別)

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系疾患の治験件数に対する視神経脊髄炎 (デビック症候群) の比率

E7諸国での治験件数:相別 (フェーズ別)

E7諸国での治験件数:進捗状況別

相別 (フェーズ別)の治験件数

  • 進行中の治験:相別 (フェーズ別)

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

視神経脊髄炎 (デビック症候群) の治療薬の治験に携わっている主要企業

有望な薬剤

治験プロファイルの概要

付録

図表

List of Tables

List of Tables

List of Tables

  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Region, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology
目次
Product Code: GDHC6467CTIDB

GlobalData's clinical trial report, "Neuromyelitis Optica (Devic's Syndrome) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Neuromyelitis Optica (Devic's Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Neuromyelitis Optica (Devic's Syndrome). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.